major published clinical trials in aki: what do they really mean? michael zappitelli, md, msc...
TRANSCRIPT
![Page 1: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/1.jpg)
Major Published Clinical Trials in AKI: What do they Really Mean?
Michael Zappitelli, MD, MScMontreal Children's HospitalMcGill University Health Centre
![Page 2: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/2.jpg)
What does “Clinical Trials in AKI” mean?
Reduce AKI incidenceTherapeuticsPreventive
Illness – PICU
Cardiac surgery
Nephrotoxin
No AKI
AKI
![Page 3: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/3.jpg)
What does “Clinical Trials in AKI” mean?
Reduce RRT needTherapeutics Preventive
Improve outcomeTherapeuticsPreventiveRRT initiation timing
Patient develops AKI
No RRT need
RRT need
Good outcome
Poor outcome
![Page 4: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/4.jpg)
What does “Clinical Trials in AKI” mean?
RRT intervention evaluationModality“Dose”TimingIntra/Post-RRT therapeutics?
SurvivalRenal recoveryComplicationsCost/Morbidity
Patient requires RRT
Good outcome
Poor outcome
![Page 5: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/5.jpg)
Overview
Major trials on dose and timing
Brief meta-analyses review
Selected adult and pediatric trials
Brief review of meta-analyses
Context of pediatric AKI and future directions
![Page 6: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/6.jpg)
Timing not standardizedDid it really answer the dose question? Allowed for different modalities
No benefit to increase HD dose > 3/week + Kt/V >1.2-1.4 ORCRRT > 20 ml/kg/hr
ATN Study
![Page 7: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/7.jpg)
RENAL study
Timing not standardized
>25 ml/kg/hr no difference
Modality not addressed
![Page 8: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/8.jpg)
Meta-analyses: similar findings
Several meta-analyses: intensity and/or renal recovery
Casey et al, Renal Failure, 2010Zhang et al, J of Critical Care, 2010Jun et al, CJASN, 2010Negash et al, Cochrane review, updated 2011
Modality - several meta-analyses: IHD vs CRRT
Tonelli et al, AJKD, 2002Rabindranath, Cochrane review, 2008Bagshaw et al, Crit Care Med, 2008
Highlight: Poor quality evidence, heterogeneity
![Page 9: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/9.jpg)
Timing and dose
“Early”: within 12 hours of inclusion“Late”: when “standard” RRT criteria used
“High”: ~40 ml/kg/hr for 70kg“Low”: ~ 15-20 ml/kg/hr for 70 kg
![Page 10: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/10.jpg)
Timing and dose
Only 2 RCT’s
Publication Bias
Heterogeneity – unable to account forlack of consensus on “early” definition
![Page 11: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/11.jpg)
Diuretics: do they help once CRRT stopped?
They excreted more sodium No difference in renal recovery
![Page 12: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/12.jpg)
AKI prevention: EPO?
![Page 13: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/13.jpg)
Extra process
![Page 14: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/14.jpg)
AKI prevention: EPO?
Biomarker selected sicker patients with worse outcomes
![Page 15: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/15.jpg)
AKI prevention: EPO?
But EPO did not alter outcome
![Page 16: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/16.jpg)
Child Remote Ischemic Preconditioning
![Page 17: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/17.jpg)
Child Remote Ischemic Preconditioning
Plasma Creatinine Estimated GFR Plasma CysC
Urine OutputUrine NGALPlasma NGAL
No effect
Too low power
?Significance of preventing 50% SCr rise?
![Page 18: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/18.jpg)
Fenoldopam: infants, biventricular anatomy
Secondary endpoints:Trend towards reduced pRIFLE AKI
Less diuretics and vasodilators in Rx group
![Page 19: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/19.jpg)
Fenoldopam
MORTALITY
![Page 20: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/20.jpg)
ANP/BNP
![Page 21: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/21.jpg)
Peak SCr
RRT Need
X
Mortality
2009 Cochrane review:Similar findings
More complications with higher dose
Useful for “prevention”, not “treatment”
ANP/BNP
![Page 22: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/22.jpg)
Must it all be about RCT's right away?
Propensity score analysis
30 day mortality
23% 43%
90-day mortality
28% 51%“Early” = latest day after surgery
“Late” = 2 days after surgery or later
![Page 23: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/23.jpg)
Other avenues with evidence
Therapeutic hypothermia Off pump versus on pump (cardiac surgery) Statins Sodium bicarbonate Anti-inflammatory agents Fenoldopam, ANP/BNP
![Page 24: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/24.jpg)
Summary & Conclusion
Dose/Intensity of RRT:• ATN/RENAL study suggest intensity above ~ 20-25 ml/kg/hr will not improve
outcomes• No pediatric data, but:
Should we be more aware of the dose we provide? Are we actually delivering what we think we are? Modality based on clinical factors
Use of diuretics to enhance water clearance unlikely to improve outcome or prevent RRT need• Does not mean they do not play important role
“Earlier” RRT initiation may be beneficial• Need to standardize definition• Pediatrics: different epidemiology, fluid overload – future trials
![Page 25: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/25.jpg)
Summary & Conclusion
Clinical trials in pediatrics ARE feasible
• We have: • Definition (s)• Biomarkers• Demonstrated importance
• Need to sort out:• Existing practice• Best outcome to study• Best population to study• Balance risk of Rx vs potential benefit• Demonstrate clinical equipoise
![Page 26: Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre](https://reader036.vdocuments.site/reader036/viewer/2022070410/56649efb5503460f94c0e95a/html5/thumbnails/26.jpg)
THANK YOU
Composium organizers: • Stuart Goldstein• Timothy Bunchman
KIDMO colleagues: • David Askenazi• Geoffrey Fleming• Matthew Paden• David Selewski• Brian Bridges• David Cooper
Cincinnati Children's Hospital Medical Centre ppCRRT members Montreal Children's Hospital AKI research team